Skip to content
Parakho

Medplus Health Services Ltd

NSE MEDPLUSBSE 543427medplusindia.com

Q1 FY27, unaudited

Revenue
₹1,879.60 Cr
Profit after tax
₹33.17 Cr

As filed with the exchange, consolidated basis.

Board meeting

Medplus Health Services Ltd has given BSE notice of a board meeting on 27 Oct 2026 to consider Q2 FY27 results. Notice · Results calendar

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations1,879.60+21.84%6,892.47
Other income19.83+32.01%71.32
Total income1,899.43+21.94%6,963.79
Employee benefit expense241.91+20.69%884.53
Finance costs33.27+21.58%120.49
Depreciation & amortisation77.92+18.75%282.87
Total expenses1,857.55+23.43%6,688.46
Profit before tax41.88−20.64%275.33
Tax expense8.71−16.43%55.72
Profit after tax33.17−21.67%219.61
Total comprehensive income33.17−21.67%221.78
Earnings per share
Earnings per share, basic₹2.76₹18.33
Earnings per share, diluted₹2.76₹18.29

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Medplus Health Services Ltd has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 101 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Consumer Discretionary › Consumer Services › Pharmacy Retail

Classification as published by BSE.

Companies also in Pharmacy Retail, in alphabetical order

All 2 companies in Pharmacy Retail

Page generated from filings held to 07 Oct 2026.